Eli Lilly leaps as weight-loss-drug sales drive earnings and 2024 outlook
Eli Lilly (LLY) - Get Free Report posted better-than-expected fourth-quarter earnings Tuesday, while issuing a robust near-term outlook, thanks in part to surging sales of its diab…
